All News #Library
Others
METIS Phase 3 Trial Met Primary Endpoint, Demonstrating a Significant Extension
27 Mar 2024 //
BUSINESSWIRE
METiS Announces License Agreement with Evopoint Biosciences
06 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support